ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 645306 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 645306; 2) Community: the network communities that were significantly associated with the response to NSC 645306; 3) Molecule: the relationships between components within communities and NSC 645306; 4) MDR: the compounds that were significantly associated with the NSC 645306.

NSC Compound Enrichment Correlation
NSC 702045 2-Propenone, 1,1'-(2,5-pyridinediyl)bis[3-(3,4-dimethoxyphenyl)- 0.0376362543535811 0.44647713
NSC 723906 1,4-di-N-oxide-6,7-difluor-2-phenylcarbonyl-3-trifluormethyl quinoxaline 0.0376362543535811 0.31020799
NSC 747651 2-CHLORO-1-NITROSOPYRIDO[3',2':4,5]PYRROLO[1,2-C]BENZOTRIAZINE 0.0376362543535811 0.32969009
NSC 750970 3-[(E)-1-(3-1-[(4-fluorophenyl)sulfonyl]-4-piperidylimidazo[1,5-a]pyridin-1-yl)methylidene]-2-indolinone 0.0376362543535811 -0.25722937
NSC 13479 Null 0.0376362543535815 0.14396235
NSC 174121 Methotrexate Derivative 0.0376362543535815 0.25910948
NSC 219734 1,8-Octanediamine, N,N'-di-9-acridinyl- (9CI) 0.0376362543535815 0.64406041
NSC 272346 1,7-Heptanediamine, N,N'-bis(2-methyl-7-nitro-4-quinolinyl)-, dihydrochloride 0.0376362543535815 0.61008001
NSC 338947 Clomesone 0.0376362543535815 0.30914232
NSC 351710 2-methylellpticinium 0.0376362543535815 0.3687201
Total:116  Current:94    [First] [Prev] [Next] [Last]